RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 56 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 2,196 | -61.9% | 0.00% | – |
| Q3 2022 | $2,000 | -99.6% | 5,757 | -99.0% | 0.00% | – |
| Q2 2022 | $474,000 | -97.2% | 556,869 | -81.8% | 0.00% | -100.0% |
| Q1 2022 | $16,885,000 | -44.8% | 3,064,499 | -3.1% | 0.00% | -50.0% |
| Q4 2021 | $30,602,000 | -30.2% | 3,161,516 | +28.9% | 0.00% | -20.0% |
| Q3 2021 | $43,858,000 | -23.9% | 2,452,869 | +3.9% | 0.01% | -28.6% |
| Q2 2021 | $57,634,000 | -3.9% | 2,361,088 | +4.4% | 0.01% | -12.5% |
| Q1 2021 | $59,956,000 | +205.3% | 2,262,499 | -12.5% | 0.01% | +166.7% |
| Q4 2020 | $19,636,000 | +68.5% | 2,587,122 | +12.1% | 0.00% | +50.0% |
| Q3 2020 | $11,656,000 | -5.3% | 2,308,274 | +12.2% | 0.00% | 0.0% |
| Q2 2020 | $12,307,000 | +135.7% | 2,058,037 | +75.4% | 0.00% | +100.0% |
| Q1 2020 | $5,222,000 | -30.6% | 1,173,574 | +48.2% | 0.00% | 0.0% |
| Q4 2019 | $7,526,000 | +29.1% | 792,152 | +6.7% | 0.00% | 0.0% |
| Q3 2019 | $5,828,000 | -42.5% | 742,333 | +9.6% | 0.00% | -50.0% |
| Q2 2019 | $10,130,000 | -7.4% | 677,188 | +12.0% | 0.00% | 0.0% |
| Q1 2019 | $10,944,000 | +105.3% | 604,669 | +82.5% | 0.00% | +100.0% |
| Q4 2018 | $5,330,000 | -29.0% | 331,397 | +5.9% | 0.00% | 0.0% |
| Q3 2018 | $7,512,000 | – | 312,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |